基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 2,965.65
成立日期: 05/02/2001
 
分析
市值分佈:
85.95%
大市值
10.00%
中市值
3.13%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:09) 總持有投資項目: 247  
0%
 
100%
     10大 (45.54%)
代號 名稱 佔比% 持有日期
IMCRImmunocore Holdings plc0.1029/04/2026
NUVBNuvation Bio0.1029/04/2026
GRFSGrifols SA0.1029/04/2026
GLPGGalapagos NV0.1029/04/2026
KALVKalVista Pharmaceuticals0.0929/04/2026
CRVSCorvus Pharmaceuticals0.0927/04/2026
FTREFortrea Holdings0.0929/04/2026
RAPPRapport Therapeutics Inc.0.0929/04/2026
MESOMesoblast Limited0.0929/04/2026
CDNACareDx0.0929/04/2026
OLMAOlema Pharmaceuticals0.0929/04/2026
SIONSionna Therapeutics Inc0.0929/04/2026
QUREuniQure NV0.0929/04/2026
GERNGeron Corp0.0929/04/2026
URGNUroGen Pharma Ltd0.0829/04/2026
ABCLAbCellera Biologics0.0829/04/2026
GLUEMonte Rosa Therapeutics0.0829/04/2026
GHRSGH Research PLC0.0829/04/2026
MBXMBX Biosciences Inc.0.0827/04/2026
VTYX--0.0828/02/2026
  1    2    3    4    5    6   7    8    9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.